Please provide your email address to receive an email when new articles are posted on . More than 70% of patients requesting assistance identified as African American. Patients who received assistance ...

ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results Patients diagnosed with hereditary RC are more prone to ...

As part of our commitment, we've once again partnered with Statista, Inc. to evaluate the implementation of Patient Reported Outcome Measures (PROMs) in the leading hospitals around the world.

A multisociety taskforce has created a method for standardizing how patient outcomes are reported for heart valve disease (HVD), regardless of which valve is being treated and how. The objectives, the ...

The U.S. Food and Drug Administration (FDA) issued its third Patient-Focused Drug Development (PFDD) guidance titled, “Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments ...